For pharmaceutical companies, patient safety has always been the priority. That’s why pyrogen detection has become a mandatory Quality Control test for release of any parenteral drug. With the Monocyte Activation Test, the only in vitro test for the detection of the full range of pyrogens (including endotoxin and non-endotoxin pyrogens), it’s now time to move away from animal-based test for pyrogen detection. The new PyroMAT® system provides pharma companies with a robust solution to make the move to in vitro Pyrogen Test with a ready-to use kit!
Laure Robert
Merck KGaA, Darmstadt, Germany
Global Product Manager
Anja Fritsch
Confarma, France
Chief Scientific Officer
Food and beverage testing and manufacturing
Language:English
Presented:
如要继续阅读,请登录或创建帐户。
暂无帐户?